Literature DB >> 22456519

Basic science for the clinician 55: CTLA-4.

Leonard H Sigal1.   

Abstract

In physiological systems, for every "yang," there must be a "yin," for uncontrolled systems can run amok. This is the case for the T-cell compartment of the immune system, where activation must be modulated, dampened, and ultimately reversed; to not apply the brakes leads to dire consequences. In less than 20 years, CTLA-4 has emerged from being an orphan, next becoming a physiological star with ever-emerging effects, and finally to being a therapeutic target-an impressive example of evolution and one that continues. Understanding the costimulatory effects and mechanisms of CTLA-4 and the redundancies intrinsic to costimulation is important in understanding T-cell function and dysfunction in disease. A future article in this series will describe inducible T-cell costimulator, which is a normal by-pass to CTLA-4's effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456519     DOI: 10.1097/RHU.0b013e31824ea103

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  3 in total

1.  Cytotoxic-T-lymphocyte antigen 4 receptor signaling for lymphocyte adhesion is mediated by C3G and Rap1.

Authors:  Yoel Kloog; Adam Mor
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

2.  Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis.

Authors:  Haiming Yu; Junlan Yang; Shunchang Jiao; Ying Li; Wei Zhang; Jiandong Wang
Journal:  Cancer Immunol Immunother       Date:  2015-04-17       Impact factor: 6.968

Review 3.  Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning.

Authors:  Dominik Wolf; Annkristin Heine; Peter Brossart
Journal:  Oncoimmunology       Date:  2014-01-03       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.